Results
Bandaram Pharma Packtech Q2 FY27 Standalone Loss, Consolidated Profit
Bandaram Pharma Packtech Board approved audited standalone and consolidated financial results for Q2 and H1 FY27 ending September 30, 2026.
Standalone operations reported a net loss of ₹41.04 lakh in